| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.07. | Solésence, Inc.: Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp | 2 | GlobeNewswire (USA) | ||
| 10.07. | SOLESENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.06. | Solésence, Inc.: Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards | 7 | GlobeNewswire (USA) | ||
| 19.05. | Solésence, Inc.: Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Alle Awards, Marking Fourth Year of Recognition | 3 | GlobeNewswire (USA) | ||
| SOLESENCE Aktie jetzt für 0€ handeln | |||||
| 15.05. | Solésence, Inc.: Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition | 2 | GlobeNewswire (USA) | ||
| 12.05. | SOLESENCE, INC. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 12.05. | Solesence targets 30% gross margin floor while aiming to return to double-digit EBITDA margins by year-end 2026 | 2 | Seeking Alpha | ||
| 12.05. | Solesence GAAP EPS of -$0.01, revenue of $13M | 2 | Seeking Alpha | ||
| 12.05. | Solesence: Umsatzrückgang und Ergebnisverlust in Q1 2026 belasten Aktie | 4 | Investing.com Deutsch | ||
| 12.05. | Solesence Reports Q1 2026 Results: Full Earnings Call Transcript | 2 | Benzinga.com | ||
| 12.05. | SOLESENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.05. | Solésence, Inc.: Solésence Launches New Skin Health Technologies: WHSPR and Chromalüm | 8 | GlobeNewswire (USA) | ||
| 29.04. | SOLESENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.04. | Solésence verstärkt Verwaltungsrat mit Finanzexperte Marc James | 12 | Investing.com Deutsch | ||
| 27.04. | Solésence, Inc. Announces Appointment of New Independent Director | 9 | GlobeNewswire (USA) | ||
| 23.04. | SOLESENCE, INC. - 10-K/A, Annual Report | 7 | SEC Filings | ||
| 31.03. | SOLESENCE, INC. - 10-K, Annual Report | 2 | SEC Filings | ||
| 31.03. | Solesence targets 30% gross margin floor in 2026 as it aims for 5% gross margin lift under Transform and Transcend | 13 | Seeking Alpha | ||
| 31.03. | Solesence Flat on Q4 Numbers | 3 | Baystreet.ca | ||
| 31.03. | Solesence GAAP EPS of $0.00, revenue of $12.5M | 2 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 17,940 | +0,90 % | Formycon stärkt Biosimilar-Produktion mit OneSource | Formycon baut sein internationales Produktionsnetzwerk weiter aus. Der Biosimilar-Entwickler hat eine strategische Partnerschaft mit dem indischen CDMO OneSource Specialty Pharma geschlossen, um die... ► Artikel lesen | |
| ONTO INNOVATION | 244,60 | +0,08 % | Can Onto Innovation Extend Its Winning Streak in Advanced Nodes Business? | ||
| KOPIN | 3,448 | +3,95 % | Fabric.AI (Nasdaq: FABC) Stockholders Ratify Kopin Strategic Partnership to Develop Neural I/o MicroLED Optical Interconnect Technology for Next Generation AI Data Centers | NEW YORK, NY, June 24, 2026 (GLOBE NEWSWIRE) -- Fabric.AI, Inc. (Nasdaq: FABC) ("Fabric.AI" or the "Company"), a fabless semiconductor company developing MicroLED-based optical interconnects for AI... ► Artikel lesen | |
| RIBER | 9,550 | 0,00 % | RIBER receives a new order from 3SP Technologies for a production platform | RIBER receives a new order from 3SP Technologies for a production platform Bezons (France), July 9, 2026 - 8:00 am (CET) - RIBER, a global market leader in molecular beam epitaxy (MBE) equipment for... ► Artikel lesen | |
| NVE | 76,00 | +0,66 % | Dividendenbekanntmachungen (18.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2A SPA IT0001233417 - 0,104 EUR AIR LIQUIDE SA FR0000120073 - 3,7 EUR ALCOA CORPORATION CDIS AU0000339426 0,1 USD 0,086 EUR ALLISON... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,169 | -2,03 % | SMOLTEK NANOTECH HOLDING AB: Smoltek joins MAXBATT together with industrial OEMs for scaling battery production | ||
| VEECO INSTRUMENTS | 47,000 | +2,82 % | Veeco Instruments Inc.: Veeco Reports First Quarter 2026 Financial Results | First Quarter 2026 Highlights: Revenue of $158.3 million, compared with $167.3 million in the same period last yearGAAP net loss of $(0.3) million, or $(0.01) loss per diluted share, compared with... ► Artikel lesen | |
| LAMPETIA | 0,180 | +38,46 % | EQS-Adhoc: Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Sonstiges
Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten
16.07.2026 / 22:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| GAUZY | 0,360 | 0,00 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F | TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on May 19, 2026... ► Artikel lesen | |
| GOMSPACE | 1,197 | +1,35 % | GomSpace A/S: GomSpace Signs 24.4 MSEK Contract with Unseenlabs | Unseenlabs extends its existing cube satellites constellation.STOCKHOLM, July 1, 2026 /PRNewswire/ -- Today, GomSpace has signed an additional contract with Unseenlabs to deliver two new... ► Artikel lesen | |
| DOTZ NANO | 0,015 | -1,34 % | DOTZ NANO LIMITED: Results of Meeting | ||
| OBDUCAT | 0,049 | +25,13 % | NGM MARKET NOTICE: #26-16 Information regarding the last day of trading in paid subscribed units and the first day of trading in warrants issued by Obducat AB | ||
| NANOVIRICIDES | 1,570 | +2,61 % | As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo | SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,157 | +7,53 % | FendX Technologies Inc.: FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program | Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection... ► Artikel lesen | |
| ACACIA RESEARCH | 3,800 | 0,00 % | ACACIA RESEARCH CORP - 8-K, Current Report |